RX-0201

null · Rexahn Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RX-0201, covering 2019-09-12 to 2020-06-30. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer [Phase 1, Phase 2]

See pricing